4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001628280-25-034531
Chief Financial Officer sold 14,827 shares at $4.26 ($63,163)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelly John Alexander Chief Financial Officer | 2025-07-03 | Sale 10b5-1 | −14,827 | $4.26 | $63,163 | 73,485 | D: show line 1 in the form |
| Open-market sales · 14,827 sh · avg $4.26 · $63,163 | |||||||
Loading xslF345X05/wk-form4_1752006603.xml…